With a panel of outside experts…
With a panel of outside experts set to weigh in [...]
With a panel of outside experts set to weigh in [...]
Eli Lilly is taking another shot at the pain market, [...]
As biopharma companies of all stripes devote more time and [...]
The program looks to support “faster, more coordinated approaches to [...]
As it prepares to launch up to three new products [...]
Stealth BioTherapeutics is looking to put its tumultuous path behind [...]
A sprawling influence campaign to promote a risky drug called [...]
Following criticism from drugmakers, Germany has scrapped its plan to [...]
The company’s SPY002 prompted a 10.7-point reduction from baseline levels [...]
Nature Index’s latest research rankings show that China continues to [...]